Flow cytometry evaluation of cell cycle arrest in A549 human non-small cell lung cancer cells and tumors following treatment with cell cycle inhibitors: A multifaceted approach to targeting cancer
April 29, 2024
Publication of CLSI H62 Validation of Assays Performed by Flow Cytometry
By Jennifer J. Stewart PhD
Using Flow Cytometry to Immunophenotype Dendritic Cells: Master Regulators of the Immune System
By Darcey L. Clark, MS DABT, Senior Biotechnology Professional
Technology Obsolescence
Darcey L. Clark, MS DABT, Senior Biotechnology Professional
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.